Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention

被引:45
作者
Jia, Shidong [1 ,4 ]
Gao, Xueliang [1 ,3 ]
Lee, Sang Hyun [1 ,4 ]
Maira, Sauveur-Michel [5 ]
Wu, Xiaoqiu [2 ,4 ]
Stack, Edward C. [2 ,4 ]
Signoretti, Sabina [2 ,4 ]
Loda, Massimo [2 ,4 ]
Zhao, Jean J. [1 ,3 ]
Roberts, Thomas M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[5] Novartis Inst BioMed Res Inc, Oncol Dis Area, Basel, Switzerland
关键词
INTRAEPITHELIAL NEOPLASIA; PTEN; CELL; EXPRESSION; DELETION; GENE; PI3K;
D O I
10.1158/2159-8290.CD-12-0262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer is an ideal target for chemoprevention. To date, chemoprevention clinical trials with 5 alpha-reductase inhibitors have yielded encouraging yet ultimately confounding results. Using a preclinical mouse model of high-grade prostatic intraepithelial neoplasia (HG-PIN) induced by PTEN loss, we observed unprecedented deteriorating effects of androgen deprivation, in which surgical castration or MDV3100 treatment accelerated disease progression of the otherwise stable HG-PIN to invasive castration-resistant prostate cancer (CRPC). As an alternative, targeting the phosphoinositide 3-kinase (PI3K) signaling pathway via either genetic ablation of genes encoding PI3K components or pharmacologic inhibition of the PI3K pathway reversed the PTEN loss-induced HG-PIN phenotype. Finally, concurrent inhibition of the PI3K and mitogen-activated protein kinase (MAPK) pathways was effective in blocking the growth of PTEN-null CRPC. Together, these data have revealed the potential adverse effects of antiandrogen chemoprevention in certain genetic contexts (such as PTEN loss) while showing the promise of targeted therapy in the clinical management of this complex and prevalent disease.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 24 条
[1]   Effect of Dutasteride on the Risk of Prostate Cancer. [J].
Andriole, Gerald L. ;
Bostwick, David G. ;
Brawley, Otis W. ;
Gomella, Leonard G. ;
Marberger, Michael ;
Montorsi, Francesco ;
Pettaway, Curtis A. ;
Tammela, Teuvo L. ;
Teloken, Claudio ;
Tindall, Donald J. ;
Somerville, Matthew C. ;
Wilson, Timothy H. ;
Fowler, Ivy L. ;
Rittmaster, Roger S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13) :1192-1202
[2]   Chromosomal imbalances, and immunohistochemical loss of heterozygosity, expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate [J].
Bettendorf, Olaf ;
Schmidt, Hartmut ;
Staebler, Annette ;
Grobholz, Rainer ;
Heinecke, Achim ;
Boecker, Werner ;
Hertle, Lothar ;
Semjonow, Axel .
GENES CHROMOSOMES & CANCER, 2008, 47 (07) :565-572
[3]   Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma [J].
Buonamici, Silvia ;
Williams, Juliet ;
Morrissey, Michael ;
Wang, Anlai ;
Guo, Ribo ;
Vattay, Anthony ;
Hsiao, Kathy ;
Yuan, Jing ;
Green, John ;
Ospina, Beatriz ;
Yu, Qunyan ;
Ostrom, Lance ;
Fordjour, Paul ;
Anderson, Dustin L. ;
Monahan, John E. ;
Kelleher, Joseph F. ;
Peukert, Stefan ;
Pan, Shifeng ;
Wu, Xu ;
Maira, Sauveur-Michel ;
Garcia-Echeverria, Carlos ;
Briggs, Kimberly J. ;
Watkins, D. Neil ;
Yao, Yung-mae ;
Lengauer, Christoph ;
Warmuth, Markus ;
Sellers, William R. ;
Dorsch, Marion .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (51)
[4]   Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer [J].
Carver, Brett S. ;
Chapinski, Caren ;
Wongvipat, John ;
Hieronymus, Haley ;
Chen, Yu ;
Chandarlapaty, Sarat ;
Arora, Vivek K. ;
Le, Carl ;
Koutcher, Jason ;
Scher, Howard ;
Scardino, Peter T. ;
Rosen, Neal ;
Sawyers, Charles L. .
CANCER CELL, 2011, 19 (05) :575-586
[5]   SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression [J].
Ding, Zhihu ;
Wu, Chang-Jiun ;
Chu, Gerald C. ;
Xiao, Yonghong ;
Ho, Dennis ;
Zhang, Jingfang ;
Perry, Samuel R. ;
Labrot, Emma S. ;
Wu, Xiaoqiu ;
Lis, Rosina ;
Hoshida, Yujin ;
Hiller, David ;
Hu, Baoli ;
Jiang, Shan ;
Zheng, Hongwu ;
Stegh, Alexander H. ;
Scott, Kenneth L. ;
Signoretti, Sabina ;
Bardeesy, Nabeel ;
Wang, Y. Alan ;
Hill, David E. ;
Golub, Todd R. ;
Stampfer, Meir J. ;
Wong, Wing H. ;
Loda, Massimo ;
Mucci, Lorelei ;
Chin, Lynda ;
DePinho, Ronald A. .
NATURE, 2011, 470 (7333) :269-+
[6]   Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers [J].
Engelman, Jeffrey A. ;
Chen, Liang ;
Tan, Xiaohong ;
Crosby, Katherine ;
Guimaraes, Alexander R. ;
Upadhyay, Rabi ;
Maira, Michel ;
McNamara, Kate ;
Perera, Samanthi A. ;
Song, Youngchul ;
Chirieac, Lucian R. ;
Kaur, Ramneet ;
Lightbown, Angela ;
Simendinger, Jessica ;
Li, Timothy ;
Padera, Robert F. ;
Garcia-Echeverria, Carlos ;
Weissleder, Ralph ;
Mahmood, Umar ;
Cantley, Lewis C. ;
Wong, Kwok-Kin .
NATURE MEDICINE, 2008, 14 (12) :1351-1356
[7]   Genetic background controls tumor development in Pten-deficient mice [J].
Freeman, Dan ;
Lesche, Ralf ;
Kertesz, Nathalie ;
Wang, Shungyou ;
Li, Gang ;
Gao, Jing ;
Groszer, Matthias ;
Martinez-Diaz, Hilda ;
Rozengurt, Nora ;
Thomas, George ;
Liu, Xin ;
Wu, Hong .
CANCER RESEARCH, 2006, 66 (13) :6492-6496
[8]   Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer [J].
Gao, Hui ;
Ouyang, Xuesong ;
Banach-Petrosky, Whitney A. ;
Gerald, William L. ;
Shen, Michael M. ;
Abate-Shen, Cory .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (39) :14477-14482
[9]  
Gioeli D, 1999, CANCER RES, V59, P279
[10]   Identification of a Cell of Origin for Human Prostate Cancer [J].
Goldstein, Andrew S. ;
Huang, Jiaoti ;
Guo, Changyong ;
Garraway, Isla P. ;
Witte, Owen N. .
SCIENCE, 2010, 329 (5991) :568-571